Crime & Justice

Purdue Pharma Doubled Down on OxyContin Marketing After $600 Million Fine

Name: Purdue Pharma Doubled Down on OxyContin Marketing After $600 Million Fine
Uploaded: 2026-06-24T12:32:00+00:00
Description: After Purdue Pharma paid a $600 million fine in 2007 and signed a consent agreement for mismarketing OxyContin, Posner discovered the company actually increased its aggressive marketing efforts rather than curtailing them. The government failed to enforce the agreement for over a decade, allowing the opioid crisis to worsen substantially while the Sacklers accumulated billions.

Danger Close · Danger Close | The Fourth Option Podcast: Gerald Posner · June 24, 2026

Danger Close

Danger Close | The Fourth Option Podcast: Gerald Posner

"I would say it's over for them. They're going to have to follow the rules. This big OxyContin problem is finished. You know what? It's astonishing to me, and it's infuriating. They went back, they ignored the consent agreement, they essentially doubled down. They got more aggressive on their marketing, and nobody in the government came back to bring them in until 2018, 2019, 2020."

After Purdue Pharma paid a $600 million fine in 2007 and signed a consent agreement for mismarketing OxyContin, Posner discovered the company actually increased its aggressive marketing efforts rather than curtailing them. The government failed to enforce the agreement for over a decade, allowing the opioid crisis to worsen substantially while the Sacklers accumulated billions.

About this episode

On this episode of the Fourth Option Podcast, host Jack Carr interviewed bestselling investigative author Gerald Posner about his groundbreaking book 'Pharma: Greed, Lies, and the Poisoning of America.' Posner, who has spent decades exposing pharmaceutical industry corruption alongside his wife Tricia, detailed the industry's evolution from Civil War-era morphine production through the modern opioid crisis. The conversation's most explosive revelation concerned early COVID-19 legislation: Posner disclosed that both parties initially included language preventing pharmaceutical companies from owning vaccine patents developed with government money, but that provision was stripped within 8 days, demonstrating pharma's bipartisan power in Washington. Posner also revealed previously unknown details about the Sackler family, including that the brothers who founded Purdue Pharma were card-carrying Communist Party members during the 1950s Cold War era, obtained through FOIA requests. The discussion covered how Purdue ignored a 2007 consent agreement and actually increased aggressive OxyContin marketing, how McKinsey advised them to 'supercharge' sales during the crisis, and how the Supreme Court recently overturned bankruptcy protections that would have shielded the billionaire Sacklers from litigation. Posner explained Arthur Sackler's invention of modern pharmaceutical marketing techniques in the 1950s and how those tactics enabled the opioid epidemic that kills 100,000 Americans annually. The episode also touched on Posner's landmark JFK assassination research in 'Case Closed' and his upcoming work on Swiss financiers who handled Nazi loot. Throughout, Posner maintained his characteristic glass-half-full outlook while documenting institutional failures, emphasizing that while pharmaceutical scientists do heroic work, marketing departments and lack of government oversight have repeatedly prioritized profits over public health.

Key takeaways

Early COVID relief bills included language preventing vaccine patent ownership by pharma companies, but that clause was removed within 8 days before passage.
The Sackler brothers who founded Purdue Pharma were card-carrying Communist Party members in the 1950s, revealed through FOIA documents.
After a $600 million fine in 2007, Purdue Pharma ignored its consent agreement and doubled down on aggressive OxyContin marketing until 2018-2020.
McKinsey & Company advised Purdue Pharma on how to supercharge OxyContin sales in 2013-2014 despite widespread knowledge of the opioid crisis.
The Supreme Court overturned bankruptcy court protections for the Sackler family, reactivating thousands of individual lawsuits against them.
Arthur Sackler invented modern pharmaceutical marketing in the 1950s, creating the drug representative model and making Valium the number one drug for 15 years.
Top pharmaceutical companies consistently spend more on share buybacks and advertising than on research and development, undermining their pricing justifications.